Due to the global surge in demand for quality drugs and medical products, the export of pharmaceuticals from the United States is also expected to grow positively in the upcoming times. Some of the large multinational companies like Pfizer, Merck, and Johnson & Johnson have been establishing a strong presence in the nation among the international markets, promoting the cutting-edge research and development capabilities of the manufacturing units to produce globally demanded commodities.

From 2020 onwards, the overall export of pharmaceuticals from the United States has recorded a hike of 4% CAGR rate in the year by trade increase, which has resulted in an export trade value of 56 billion US dollars in 2021. The high demand for American-made pharmaceuticals across various regions in the world and the advancement of the innovative healthcare industry producing global essentials has boosted the annual export of pharmaceuticals by a rate of 5.6% in 2024 worth the valuation of 130 billion US dollars.

The Significance of Pharmaceutical Export in the United States Economy

The pharmaceutical sector long been a crucial role player in the economy of the United States has solidified itself as a role player in the entire trade landscape. America, being one of the largest global exporters of pharmaceuticals, has recorded itself as a trade holder of 44% of the global pharmaceutical exports in the year 2020, with a total valuation of 54 billion US dollars. The sector employs over 800,000 people directly and supports millions more through related industries such as research and development, marketing, logistics, and manufacturing, increasing the employment rate crucially.

It has been specified that pharmaceutical exports have been serving as a cornerstone for the country to maintain a favorable trade balance with foreign markets by reducing the dependence on imports. It is not only responsible for boosting local business but also strengthens the country's position as an export powerhouse in the international trade market. Thus, it can be said that the significance of pharmaceutical exports in the economy of the United States has been very essential as they provide job opportunities, boost the GDP value, strengthen the trade balance, support other industries, and also fund research and development initiatives for an overall recovery of the economy.

A Brief Overview of the United States Trade of 2024

Leading Pharmaceuticals Export of the United States in 2024

The country maintaining its position as one of the top holders of pharmaceutical products worldwide, driven by its robust research and development ecosystem has introduced diversification in the manufacturing capacities fostering the export. According to the USA Export Data; the top 10 leading variants of pharmaceuticals exported from the nation in 2024 are,

1. Anti-cancer Drugs - Export valuation - 48 billion US dollars; Annual trade share - 32%

2. Vaccines - Export valuation - 27 billion US dollars; Annual trade share - 24%

3. Cardiovascular Nedications - Export valuation - 18 billion US dollars; Annual trade share - 18%

4. Antidepressants - Export valuation - 12 billion US dollars; Annual trade share - 10%

5. Antibiotics - Export valuation - 10 billion US dollars; Annual trade share - 5%

6. Painkillers - Export valuation - 8 billion US dollars; Annual trade share - 4%

7. Hormonal Therapies - Export valuation - 6 billion US dollars; Annual trade share - 3%

8. Respiratory Medications - Export valuation - 5 billion US dollars; Annual trade share - 2.5%

9. Anti-Diabetic Drugs - Export valuation - 4 billion US dollars; Annual trade share - 2%

10. Dermatological Medications - Export valuation - 3 billion US dollars; Annual trade share - 1.8%

Major Export Trade Partners of the United States for Pharmaceuticals Export in 2024

The United States has started exporting most of its pharmaceuticals produced domestically with the importing destination having cost-effective pricing strategies and a lower rate of tariff rates over foreign trades. According to the USA Trade Data, the top 10 export trade partners of the nation for pharmaceuticals in 2024 are,

1. Canada - As per the Canada Import Data, the total valuation of pharmaceuticals exported from the United States in 2024 - 52 billion US dollars.

2. Mexico - As per the Mexico Import Data, the total valuation of pharmaceuticals exported from the United States in 2024 - 35 billion US dollars.

3. Japan - As per the Japan Import Data, the total valuation of pharmaceuticals exported from the United States in 2024 - 22 billion US dollars.

4. Germany - As per the Germany Import Data, the total valuation of pharmaceuticals exported from the United States in 2024 - 18 billion US dollars.

5. United Kingdom - As per the United Kingdom Import Data, the total valuation of pharmaceuticals exported from the United States in 2024 - 15 billion US dollars.

6. Belgium - As per the Belgium Import Data, the total valuation of pharmaceuticals exported from the United States in 2024 - 12 billion US dollars.

7. South Korea - As per the South Korea Import Data, the total valuation of pharmaceuticals exported from the United States in 2024 - 10 billion US dollars.

8. Brazil - As per the Brazil Import Data, the total valuation of pharmaceuticals exported from the United States in 2024 - 8 billion US dollars.

9. Australia - As per the Australia Import Data, the total valuation of pharmaceuticals exported from the United States in 2024 - 6 billion US dollars.

10. Netherlands - As per the Netherlands Import Data, the total valuation of pharmaceuticals exported from the United States in 2024 - 5 billion US dollars.

Top Pharmaceutical Manufacturing Companies of the United States in 2024

The United States has solidified its position as a leading global pharmaceutical exporter due to its innovative drug manufacturers. The companies play a critical role in advancing medical research to produce life-saving therapies, which drive economic growth through exports and employment. According to the USA Customs Data, the top pharmaceutical manufacturing companies of the nation in 2024 are,

1. Pfizer Inc. - It is a globally leading pharmaceutical manufacturing company with headquarters based in New York City. Pfizer has established itself as a powerhouse in research and development due to the innovative medicine production for various diseases. Different global essentials like vaccines to oncology drugs from Pfizer have boosted the company's annual trade share by 32% in 2024.

2. Merck & Co., Inc. - Merck and Co. Inclusive mostly known as Merck Sharp and Dome, located outside of North America, has been playing a crucial role in the pharmaceutical export economy of the United States with quality medicine supply in the global market. The major focus of the authority in producing cardiovascular medicines accompanied by Diabetic and Cancer Treatment has boosted the annual trade share by 20% in 2024.

3. Johnson & Johnson - This multinational corporation operates throughout the region via three main segments. Consumer health products, pharmaceutical products, and medical devices are some of the mostly supplied pharmaceuticals from Johnson & Johnson in 2024. The pharmaceutical products contribute significantly to the annual trade share of America, with an overall revenue rate of 16% in 2024.

Conclusion - The pharmaceutical export performance of the United States is one of the enduring strengths of the nation in the global healthcare market. Import Globals with the United States trade data highlights all the regional shipments of pharmaceuticals ranging from high-value medicines to cutting-edge biologics to leading importing destinations. The trade sheet helps the business owners understand the potential marketing zones, through active monitoring of the competitors' engagements, to make decisions based on the latest modern strategies of the global market.

FAQ’s

Que. What is the export trade value of pharmaceuticals from the United States in 2024?
Ans. The export trade value of pharmaceuticals from the United States in 2024 is 130 billion US dollars.

Que. Who is the top export trade partner of the United States for pharmaceuticals in 2024?
Ans. Canada is the top export trade partner of the United States for pharmaceuticals in 2024.

Que. Who is the top pharmaceutical manufacturing company of the United States in 2024?
Ans. Pfizer Inc. is the top pharmaceutical manufacturing company of the United States in 2024.

Que. Where can you get a detailed trade analysis of the pharmaceutical export of the United States in 2024?
Ans. By subscribing to Import Globals, you can get a detailed trade analysis of the pharmaceutical export of the United States in 2024.

www.importglobals.com ; info@importglobals.com